Literature DB >> 11238042

Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.

C Berking1, R Takemoto, K Satyamoorthy, R Elenitsas, M Herlyn.   

Abstract

Ultraviolet (UV) light is an epidemiological risk factor for melanoma, but its specific contribution to melanoma induction is not known. The first critical step of melanoma development, ie, the uncontrolled proliferation of melanocytes, may be induced by a combination of UV damage and an imbalance of growth factor production by cells in the immediate area of the melanocyte. Among several candidates, basic fibroblast growth factor (bFGF) is the major autocrine growth factor in melanoma and associated with tumor progression. Overexpression of bFGF via adenoviral gene transfer in human skin xenografted to severe combined immunodeficiency mice led to black-pigmented macules within 3 weeks of treatment. Immunofluorescence analysis demonstrated pathological hyperpigmentation, proliferation and hyperplasia of activated melanocytes, but no malignant transformation. Similar changes were observed in skin reconstructs. When bFGF was combined with UVB, pigmented lesions with hyperplastic melanocytic cells were detected, including a lesion with high-grade atypia resembling lentiginous forms of malignant melanoma. Donor-matched control grafts revealed no melanocytic changes. bFGF was overexpressed in dermal fibroblasts demonstrating the co-carcinogenic influence of paracrine-acting growth factors by cells of the microenvironment. This is the first report suggesting that an imbalance of physiological growth factor production in the skin may cause melanoma in combination with UVB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238042      PMCID: PMC1850339          DOI: 10.1016/S0002-9440(10)64041-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  Autocrine and paracrine roles for growth factors in melanoma.

Authors:  I M Shih; M Herlyn
Journal:  In Vivo       Date:  1994 Jan-Feb       Impact factor: 2.155

2.  Expression of basic fibroblast growth factor in desmoplastic melanoma.

Authors:  S al-Alousi; J A Carlson; K Blessing; M Cook; T Karaoli; R L Barnhill
Journal:  J Cutan Pathol       Date:  1996-04       Impact factor: 1.587

3.  Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex.

Authors:  P Mignatti; T Morimoto; D B Rifkin
Journal:  J Cell Physiol       Date:  1992-04       Impact factor: 6.384

4.  Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes.

Authors:  M Brauchle; J O Funk; P Kind; S Werner
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

5.  UVB induces IL-12 transcription in human keratinocytes in vivo and in vitro.

Authors:  C D Enk; S Mahanty; A Blauvelt; S I Katz
Journal:  Photochem Photobiol       Date:  1996-06       Impact factor: 3.421

6.  IL-8 gene expression and production in human keratinocytes and their modulation by UVB.

Authors:  S Kondo; T Kono; D N Sauder; R C McKenzie
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

7.  UV irradiation-induced interleukin-1 and basic fibroblast growth factor synthesis and release mediate part of the UV response.

Authors:  M Krämer; C Sachsenmaier; P Herrlich; H J Rahmsdorf
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

8.  Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor.

Authors:  E Gohda; T Matsunaga; H Kataoka; T Takebe; I Yamamoto
Journal:  Cytokine       Date:  1994-11       Impact factor: 3.861

9.  Malignant melanoma in ultraviolet irradiated laboratory opossums: initiation in suckling young, metastasis in adults, and xenograft behavior in nude mice.

Authors:  E S Robinson; J L VandeBerg; G B Hubbard; T P Dooley
Journal:  Cancer Res       Date:  1994-11-15       Impact factor: 12.701

Review 10.  Growth factors, receptor kinases, and protein tyrosine phosphatases in normal and malignant melanocytes.

Authors:  R Halaban; B Fan; J Ahn; Y Funasaka; H Gitay-Goren; G Neufeld
Journal:  J Immunother (1991)       Date:  1992-10
View more
  14 in total

1.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

2.  Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.

Authors:  Oddbjørn Straume; Lars Andreas Akslen
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

3.  Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression.

Authors:  Klara Balint; Min Xiao; Chelsea C Pinnix; Akinobu Soma; Imre Veres; Istvan Juhasz; Eric J Brown; Anthony J Capobianco; Meenhard Herlyn; Zhao-Jun Liu
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

4.  Expression of fibroblast growth factor binding protein in head and neck cancer.

Authors:  Weimin Li; Chuan Wang; Steven K Juhn; Frank G Ondrey; Jizhen Lin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-09

5.  The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes.

Authors:  Hong Yu; Ronan McDaid; John Lee; Patricia Possik; Ling Li; Suresh M Kumar; David E Elder; Patricia Van Belle; Phyllis Gimotty; Matt Guerra; Rachel Hammond; Katharine L Nathanson; Maria Dalla Palma; Meenhard Herlyn; Xiaowei Xu
Journal:  Am J Pathol       Date:  2009-04-23       Impact factor: 4.307

6.  Targeting nitric oxide signaling with nNOS inhibitors as a novel strategy for the therapy and prevention of human melanoma.

Authors:  Zhen Yang; Bobbye Misner; Haitao Ji; Thomas L Poulos; Richard B Silverman; Frank L Meyskens; Sun Yang
Journal:  Antioxid Redox Signal       Date:  2013-01-18       Impact factor: 8.401

7.  Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Authors:  Daniela Göppner; Martin Leverkus
Journal:  J Skin Cancer       Date:  2011-10-11

8.  FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription.

Authors:  L Dong; Y Li; J Cao; F Liu; E Pier; J Chen; Z Xu; C Chen; R-A Wang; R Cui
Journal:  Cell Death Differ       Date:  2011-10-14       Impact factor: 15.828

9.  CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1.

Authors:  Mizuho Fukunaga-Kalabis; Gabriela Martinez; Zhao-Jun Liu; Jiri Kalabis; Paul Mrass; Wolfgang Weninger; Sue M Firth; Nathalie Planque; Bernard Perbal; Meenhard Herlyn
Journal:  J Cell Biol       Date:  2006-11-13       Impact factor: 10.539

10.  Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study.

Authors:  Hongmei Nan; Abrar A Qureshi; David J Hunter; Jiali Han
Journal:  BMC Cancer       Date:  2009-06-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.